Today Soligenix was granted
a patent to produce a topical agent to treatment for treatment in pediatric
Crohn’s disease. It should be noted that pediatric Crohn’s is a little
different than Crohn’s in adults due to the different issues that are faced
with younger patients (height, health, weight). The drug works with
beclomethasone dipropionate which works in the upper and lower gastrointestinal
tract. The drug has been used since the 1970s and Soligenix is trying to
develop an oral form of the medication. The company will start trials that
should be started this year on SGX203 (oral form). Hopefully another future
drug that can be used in the drug arsenal against Crohn’s!
No comments:
Post a Comment